Turnip mosaic virus presents itself not as a pathogen in mammalian biology, but as a filamentous protein object with molecular regularity and mesoscopic length. In aqueous media these filaments drift, collide, and entangle into a stochastic nanomesh, building a percolated network that overlays soft matter like a gauze at the scale of the cytoskeleton. Gelatin-methacryloyl, derived from collagen and photopolymerized into hydrated solids, already carries integrin-engaging motifs that cells recognize, but its microenvironment often lacks nanoscale architectural guidance. Introducing plant-derived filaments into this hydrogel is less about adding mass and more about adding topology, because the viral coat repeats into a continuous scaffold that cells can sense through focal adhesions. The material pairing exploits orthogonality: a mammalian-compatible hydrogel provides biochemical invitation, while a plant viral nanomesh introduces mechanical and spatial cues without replicative risk. Framed this way, the composite is not a simple filler system but a hierarchical matrix where protein sequence, supramolecular geometry, and bulk mechanics can be independently tuned.
The physical form of these particles matters as much as their chemistry, because elongated objects couple strongly to viscoelastic networks and resist rotational diffusion. As hydrogels equilibrate, filaments settle into jammed ensembles that resist shear at low strains yet remain compliant to larger deformations, thus setting the stage for cell-mediated remodeling. Cells approaching such a mesh experience a nanoscale landscape of ridges and voids that redirects lamellipodia, biases filopodial probing, and redistributes tension across actin bundles. In practice, that means the same polymer backbone can elicit different morphologies depending on whether a nanomesh is present, even when bulk stiffness is held constant. The result is a decoupling of biochemical adhesion from topographic instruction, allowing investigators to ask which cue governs spreading, alignment, or quiescence. This separation of variables is precisely what is needed to move from generic growth support toward tissue-specific morphogenesis.
Safety and manufacturability sit beside performance in any translational conversation, and plant viruses offer useful advantages here. Their proteinaceous shells lack the tropism required for mammalian infection, avoiding the genomic concerns that shadow some viral platforms from other kingdoms. Production in plants leverages low-cost, scalable cultivation while sidestepping endotoxin control, and purification relies on well-established density and solvent steps that preserve particle integrity. Because the capsid repeats a single coat protein in high copy, the surface presents a dense, uniform array of reactive amines that chemists can address without complex folding worries. This repeat chemistry transforms each filament into a programmable scaffold for ligands, dyes, or crosslinkers, enabling modular designs that read like a molecular parts list. When embedded in GelMA, that modularity becomes spatially anchored, so biochemical signals ride on a mechanically continuous, nanoscale threadwork rather than diffusing away.
Conceptually, the composite functions as an engineered analogue of fibrillar extracellular matrix. GelMA supplies denatured-collagen motifs that engage integrins, while the viral filaments supply persistent line elements that mimic collagen’s aspect ratio and network connectivity. Together they generate a milieu where cells feel both biochemical permission and architectural instruction, much as they would in native stroma. This duality proves useful across lineage contexts, from fibroblasts that survey and contract to myoblasts that align and fuse under anisotropic guidance. Because the viral network self-assembles without external templating, it serves as a plug-in nanoscale layer that can overlay cast constructs, flow-spun filaments, or printed lattices. That portability allows one formulation to support multiple biofabrication routes, which is a practical route to platform-level tissue engineering.
When fibroblasts encounter a pristine GelMA surface, they typically recognize adhesion motifs, spread broadly, and knit into confluent sheets that blur single-cell boundaries. Layer a viral nanomesh onto the same hydrogel and the choreography changes, even when viability and metabolic readouts remain indistinguishable. Cells gather into clusters, extend longer processes, and adopt elongated forms, suggesting that contact guidance has supplanted isotropic spreading as the dominant cue. This shift implies that the nanomesh partially occludes adhesive sites or redistributes them into corridors that favor polarity, which is a classical mechanism by which nanotopography reprograms cytoskeletal architecture. The actin cytoskeleton reorganizes accordingly, with stress fibers aligning along perceived tracks and focal adhesions stabilizing at extended ends. Such behavior signals that topology alone can redirect phenotype without altering the underlying hydrogel chemistry or crosslink density.
This elongated phenotype has mechanical consequences because shape sets the load path for intracellular tension. Slender cells generate anisotropic traction fields, which in turn feed back to matrix remodeling through integrin-mediated signaling. On a GelMA–TuMV surface, those feedback loops likely proceed along filament-parallel axes, reinforcing alignment and stabilizing elongated morphologies. Over time this can produce microdomains with preferred orientation, even in the absence of external strain or patterned photopolymerization. In tissues where alignment predicts function, such as tendon or muscle, the ability to induce anisotropy without prestrain is valuable. The viral filaments thus serve as silent architects, seeding order at a scale the bulk hydrogel cannot address.
Importantly, the nanomesh does not automatically enhance adhesion in its naïve form, a reminder that topography and ligand chemistry must be co-designed. GelMA’s native motifs confer adhesion, but if coverage by protein filaments is too extensive, cells may treat the interface as less hospitable, at least initially. That tension can be resolved by decorating the filaments with bioactive ligands, transforming the same topographic element into an adhesive track. Before such functionalization, however, the system is a clean test bed for isolating purely physical guidance effects. It shows that cells read nanoscale architecture even when biochemical context is unchanged, which is instructive for designing orthogonal libraries of cues. The lesson is straightforward: geometry alone is a potent transcriptomic lever when delivered at the right scale.
These observations translate across biofabrication formats, which strengthens the case for generality. Cast disks coated with filaments maintain shape and support cluster-to-confluence transitions that favor uniform coverage. Flow-drawn fibers with filament coatings host myoblasts that align along narrow widths, recapitulating the anisotropy required for contractile maturation. In printed lines, embedding filaments in the ink maintains topology through extrusion, ensuring the nanoscale landscape survives shear on its way to a crosslinked lattice. Across these formats, the viral component acts as a portable layer of architectural information that rides on a widely used hydrogel. Such portability supports iteration, allowing tuning of mesh density, filament orientation, and interfacial chemistry without rewriting the base ink.
Turning a passive nanomesh into an instructive scaffold requires site-specific chemistry that is gentle, aqueous, and compatible with protein architecture. The coat protein of the filament displays primary amines that readily accept NHS-activated handles, enabling downstream ligations under physiological conditions. A phosphine–azide ligation, executed as a Staudinger coupling, provides a clean way to tether growth factors without harsh catalysts or photoinitiators that might denature sensitive ligands. By first installing a phosphine on the filament and an azide on epidermal growth factor, one can drive a selective reaction that links ligand to capsid while leaving the hydrogel untouched. This modular sequence yields a multivalent display, where each filament presents many copies of the growth cue in a spatial arrangement cells can sense at the nanoscale. Such multivalency exploits receptor clustering biology, enhancing signaling even when total ligand mass is modest.
When fibroblasts are cultured on hydrogels bearing the functionalized nanomesh, the surface begins to act like a presentation platform rather than a passive landscape. Cells achieve more uniform coverage, with fewer barren patches and smoother edges, signaling that adhesive engagement has improved. The morphology shifts away from extreme elongation toward a balanced state that still respects topographic guidance but no longer sacrifices overall confluence. This pattern suggests that the multivalent arrangement promotes receptor engagement that stabilizes adhesions and encourages cell cycle progression. In contrast, adding soluble growth factor without anchoring it to the mesh fails to reproduce the spatially coherent outcome, highlighting the importance of localized, sustained presentation. The filament therefore serves both as a nanoscale ruler and as a ligand reservoir, marrying mechanics and biochemistry in a single construct.
Electron microscopy confirms that the functionalization preserves filament geometry, which is critical for maintaining topographic instruction. The surface conjugation thickens the apparent contour only subtly, leaving length and flexibility intact so that entanglement behavior persists. That means the same self-assembly that created the original nanomesh now carries a biologically decorated version into the hydrogel, without requiring new processing conditions. Because the conjugation uses widely available reagents and proceeds in buffered media, it is amenable to scale-up and to substitution with other ligands or peptides. One can imagine libraries of meshes bearing osteogenic, angiogenic, or neurotrophic cues, each distributed with similar nanoscale periodicity. In this way, the capsid becomes a scaffold for multiplexed signaling, not just a physical fiber.
The broader implication is that growth factor economy improves when presentation is multivalent and immobilized. Soluble factors diffuse and dilute, prompting repeated dosing to sustain signaling, whereas a tethered array remains where cells need it and amplifies local receptor engagement. That shift reduces waste and lowers exposure of non-target regions, which matters in complex constructs with gradients or compartments. It also invites combinatorial patterning, where different filaments carry different ligands and assemble into interpenetrating networks with distinct biological messages. Because GelMA supports photopatterning, one can align these networks to create tissues with spatially resolved microenvironments. The end result is a design language in which chemistry, topology, and spatial control reinforce one another.
A hydrogel–nanomesh that only works in a dish is a curiosity; one that survives fabrication is a platform. Casting remains the simplest route, and disks formed in ultra-low-adhesion wells accept filament coatings without losing integrity or shape. Cells seeded onto these disks sense both the base hydrogel chemistry and the nanoscale overlay, producing coverage that is more uniform when growth factor decoration is present. This straightforward workflow can be stacked, enabling multilayer assemblies where each disk carries a defined nanomesh density or ligand identity. Because the mesh forms by simple adsorption, the process adds minimal complexity and no harsh processing that would jeopardize embedded cells. These features make disks useful as building blocks for thicker constructs that still preserve nanoscale instruction.
Flow-assisted fiber fabrication adds anisotropy, which many musculoskeletal tissues demand. By exposing droplets of prepolymer to controlled surface flows before crosslinking, one can draw long, slender filaments whose curvature and width change gradually along their length. Coating these fibers with the viral nanomesh biases myoblasts toward axial alignment, a prerequisite for myofiber maturation and eventual contractility. The narrower regions amplify guidance because cells encounter stronger curvature and tighter confinement, which synergizes with the filament topology. Over culture time, aligned sheets appear on the fiber surface, and detachment events are less frequent when the mesh is present, suggesting improved interfacial robustness. These observations make flow-spun fibers a promising format for building oriented bundles that emulate fascicular architecture.
Three-dimensional bioprinting imposes different constraints, because inks must shear-thin in the nozzle, recover structure on deposition, and crosslink reproducibly. Embedding the viral filaments directly in the GelMA prepolymer yields a bioink whose viscosity–temperature profile remains close to that of the base hydrogel, preserving predictable extrusion behavior. Fluorescent labeling of filaments shows that their dispersion persists through printing, with the nanoscale signal present throughout filament cross-sections. When living cells are included, the presence of the nanomesh helps maintain line fidelity, likely by modulating microstructure recovery and resisting undesired spreading after deposition. Cells remain viable immediately after printing and continue to populate the printed strands over extended culture, demonstrating compatibility with extrusion and photopolymerization. This combination of printability and nanoscale instruction sets the stage for lattice-level designs that also carry submicron guidance.
Print fidelity is not a single number but a balance across line thickness, uniformity, and reproducibility. Inks containing cells often deposit slightly thicker lines because cells disrupt crosslinking kinetics and increase local mass flux, especially at higher pressures. Adding filaments shifts that balance back toward thinner, more uniform lines, suggesting a rheological benefit that manifests during the brief recovery window after extrusion. Because the embedded nanomesh also carries biochemical payloads when functionalized, printed lattices can couple shape fidelity with immediate biological instruction. That coupling is powerful in complex constructs where overhangs, gradients, or interfaces make traditional post-seeding inefficient. In such contexts, a single print step can deliver architecture, mechanics, and localized signaling in one pass.
Any material that aims for implantation must address fate and response in vivo, not just function in vitro. Protein filaments derived from plants are expected to undergo proteolysis over time, clearing through normal pathways rather than persisting indefinitely. Circulatory experiments in small animals with labeled particles indicate that blood residence is transient and that reticuloendothelial organs accumulate signal early, which aligns with protein clearance biology. What remains unresolved is the behavior of filaments when immobilized within hydrogels and placed into tissue beds, where enzyme access, fluid flow, and cellular uptake differ markedly. That gap motivates dedicated biodistribution and degradation studies in relevant defect models, with attention to both local remodeling and systemic exposure. Until then, the prudent stance is to design for degradability, monitor immune engagement, and avoid unnecessary payloads that might potentiate adjuvancy.
Immunogenicity is the second pillar of translational readiness. Some plant viruses act as potent immune trainers, which is an asset in vaccine development but a liability in regenerative scaffolds that aim for quiet integration. The solution is not to eschew the platform but to tame it, selecting capsids with lower innate stimulation profiles or cloaking surfaces with zwitterionic or mucin-mimetic chemistries. Ligand choice matters too, because growth factors or peptides can either quell or amplify responses depending on dose and presentation. In composite constructs, the hydrogel can be formulated to buffer early events, limiting diffusion of residual reagents and presenting a benign interface as the body encounters the implant. Such layered design keeps the benefits of nanoscale guidance while minimizing unwanted immune drama.
Design space opens further when one considers gradient and patterning strategies. Photopatterned GelMA can localize stiffness or porosity, while the viral nanomesh can localize biochemistry or topography, and the two can be registered with micron-scale precision. That registration enables constructs that present different cues across interfaces, for instance osteogenic signals where bone meets tendon and myogenic guidance where tendon meets muscle. Because the filaments self-assemble without precise alignment requirements, patterning can be achieved by simple masking of adsorption steps or selective illumination of ligand-bearing regions. In thick constructs, stacked disks or printed layers can carry distinct meshes, producing through-thickness variations that echo native tissue zonation. With such tools, the platform moves beyond homogenous gels toward architected tissues with spatial intelligence.
Finally, the path to clinical utility runs through manufacturability, reproducibility, and regulatory clarity. Plant-based production scales with agriculture rather than fermentation, which offers cost advantages but requires standardization of growth, harvest, and purification. Analytical methods must quantify particle integrity, ligand density, and residual reagents, tying those metrics to functional assays that predict in vivo performance. Sterilization and storage conditions need to preserve both capsid structure and ligand activity, which rules out some common approaches and invites gentler alternatives. Collaboration between materials scientists, virologists, and clinicians can align scaffold specifications with surgical realities, ensuring that inks print cleanly in the operating room and that constructs fit anatomical constraints. With those systems in place, viral threads in living gels can advance from elegant laboratory composites to devices that repair and regenerate.
Study DOI: https://doi.org/10.3389/fbioe.2022.907601
Engr. Dex Marco Tiu Guibelondo, B.Sc. Pharm, R.Ph., B.Sc. CpE
Editor-in-Chief, PharmaFEATURES


Embedding nitrate-driven nitric-oxide release within PCL grafts programmatically guides vascular regeneration across the lumen, media, and progenitor niche.

GelMA hydrogels demonstrate that the architecture of matter itself can modulate the architecture of inflammation.
Igor Nasonkin’s systems-driven approach at Phythera Therapeutics reframes oncology drug development from single-target inhibition to AI-enabled polypharmacologic network modulation using nature-derived molecular architectures.
Devin Swanson’s leadership at Johnson & Johnson Innovative Medicines redefines external innovation as a tightly governed, AI-enabled translational system integrating multi-modal drug discovery, biomarker strategy, and capital-efficient execution.
A systems-level examination of how Mehran F. Moghaddam operationalizes DMPK, externalized R&D, and lipid-mediated therapeutics into a predictive, high-velocity biotech development architecture.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings